Clinical Trial Update: Efficacy Study of CDP870 in Subjects With Chronic Plaque Psoriasis Who Are Candidate for Systemic Therapy and/or Phototherapy/Photochemotherapy [Phase 2]

View source ↗

Summary

Phase 2 efficacy study of CDP870 in chronic plaque psoriasis completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• CDP870 (certolizumab pegol)

Snippet

Sponsor: UCB Pharma | Conditions: Chronic Plaque Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2019-05-03